查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1339319

虛擬臨床試驗市場、份額、規模、趨勢、產業分析報告：按設計、適應症、按階段、按地區、按細分市場、預測，2023-2032 年

Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球虛擬臨床試驗市場規模預計將達到285.4408億美元。 該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

不斷增加的研發活動、醫療保健數位化以及遠距醫療的採用正在推動虛擬臨床試驗市場的發展。 這些因素使得臨床試驗中虛擬測試、遠端參與和監控的無縫整合成為可能。 機構間合作和政府支持措施也促進了市場成長。 這些趨勢凸顯了業界對虛擬方法的關注，這些方法提供靈活性、效率並提高患者對臨床試驗的參與度。

COVID-19 疫情對臨床試驗產生了重大影響，導致虛擬試驗的採用率增加。 病患招募和保留方面的挑戰擾亂了正在進行的臨床試驗。 虛擬試驗已成為疫情期間的一個重要解決方案，它允許參與者在家中參與，並確保研究的連續性，即使無法進行現場訪問。

虛擬試驗具有許多優勢，包括遠端收集數據、提高參與者的參與度以及納入更多的人群。 最大限度地減少與親自拜訪相關的風險，並減輕參與者、協調員和調查員的負擔。 透過利用虛擬方法，臨床試驗產業可以克服挑戰、提高效率並促進快速有效的數據收集。

虛擬臨床試驗市場報告亮點

2022年，由於市場區隔趨勢對創新藥物的需求以及試驗需求的增加，因此幹預設計領域主導了市場。

由於癌症發病率上升以及在 COVID-19 大流行期間採用虛擬試驗來確保患者安全，預計癌症細分市場將在 2022 年引領市場並保持其主導地位。

由於大型製藥公司、政府投資以及Janssen和 PRA Health Sciences 在心臟衰竭患者中進行的分散式卡格列淨試驗等研究合作，北美在全球虛擬臨床試驗市場中佔據了巨大的收入份額。

目錄

第一章簡介

第 2 章執行摘要

第三章研究方法

第 4 章全球虛擬臨床試驗市場洞察

  • 虛擬臨床試驗市場 - 階段快照
  • 虛擬臨床試驗市場動態
    • 推動者和機會
      • 技術進步
      • 讓研究人員接觸到更多樣化的全球患者群體
    • 抑制因素和挑戰
      • 資料安全與隱私問題
  • PESTEL 分析
  • 虛擬臨床試驗市場的階段趨勢
  • 價值鏈分析
  • COVID-19 感染的影響分析

第五章設計的全球虛擬臨床試驗市場

  • 主要發現
  • 簡介
  • 觀察測試
  • 幹預試驗
  • 擴充存取測試

第 6 章全球虛擬臨床試驗市場（按適應症）

  • 主要發現
  • 簡介
  • 中樞神經系統
  • 自體免疫/炎症
  • 循環系統疾病
  • 新陳代謝/內分泌學
  • 傳染病
  • 腫瘤學
  • 泌尿系統
  • 眼科

第 7 章全球虛擬臨床試驗市場（按階段）

  • 主要發現
  • 簡介
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第 8 章全球虛擬臨床試驗市場（按地區）

  • 主要發現
  • 簡介
    • 2019-2032 年虛擬臨床試驗市場評估（按地區）
  • 虛擬臨床試驗市場 - 北美
    • 北美：虛擬臨床試驗市場（依設計），2019-2032 年
    • 北美：虛擬臨床試驗市場（按階段），2019-2032 年
    • 北美：虛擬臨床試驗市場，依適應症劃分，2019-2032 年
    • 虛擬臨床試驗市場 - 美國
    • 虛擬臨床試驗市場 - 加拿大
  • 虛擬臨床試驗市場 - 歐洲
    • 歐洲：虛擬臨床試驗市場（依設計），2019-2032 年
    • 歐洲：虛擬臨床試驗市場，依階段劃分，2019-2032 年
    • 歐洲：虛擬臨床試驗市場（按適應症），2019-2032 年
    • 虛擬臨床試驗市場 - 英國
    • 虛擬臨床試驗市場 - 法國
    • 虛擬臨床試驗市場 - 德國
    • 虛擬臨床試驗市場 - 義大利
    • 虛擬臨床試驗市場 - 西班牙
    • 虛擬臨床試驗市場 - 荷蘭
    • 虛擬臨床試驗市場 - 俄羅斯
  • 虛擬臨床試驗市場 - 亞太地區
    • 亞太地區：虛擬臨床試驗市場（依設計），2019-2032 年
    • 亞太地區：虛擬臨床試驗市場（按階段），2019-2032 年
    • 亞太地區：虛擬臨床試驗市場（按適應症），2019-2032 年
    • 虛擬臨床試驗市場 - 中國
    • 虛擬臨床試驗市場 - 印度
    • 虛擬臨床試驗市場 - 馬來西亞
    • 虛擬臨床試驗市場 - 日本
    • 虛擬臨床試驗市場—印度尼西亞
    • 虛擬臨床試驗市場—韓國
  • 虛擬臨床試驗市場 - 中東和非洲
    • 中東與非洲：虛擬臨床試驗市場（依設計），2019-2032 年
    • 中東與非洲：虛擬臨床試驗市場（按階段），2019-2032 年
    • 中東與非洲：虛擬臨床試驗市場（按適應症），2019-2032 年
    • 虛擬臨床試驗市場 - 沙烏地阿拉伯
    • 虛擬臨床試驗市場 - 阿拉伯聯合大公國
    • 虛擬臨床試驗市場 - 以色列
    • 虛擬臨床試驗市場 - 南非
  • 虛擬臨床試驗市場 - 拉丁美洲
    • 拉丁美洲：虛擬臨床試驗市場（依設計），2019-2032 年
    • 拉丁美洲：虛擬臨床試驗市場，按階段劃分，2019-2032 年
    • 拉丁美洲：虛擬臨床試驗市場（按適應症），2019-2032 年
    • 虛擬臨床試驗市場 - 墨西哥
    • 虛擬臨床試驗市場 - 巴西
    • 虛擬臨床試驗市場 - 阿根廷

第九章競爭態勢

  • 擴張與收購分析
    • 放大
    • 收購
  • 夥伴關係/協作/協議/揭露

第十章公司簡介

  • LEO Innovation Lab
  • Covance Inc
  • CRF Health
  • Oracle Corporation
  • Medable, Inc
  • Paraxel International
  • Clinical Ink, Inc
  • PRA Health Sciences
  • Science 37
  • ICON plc
Product Code: PM1731

The global virtual clinical trials market size is expected to reach USD 28,544.08 million by 2032, according to a new study by Polaris Market Research. The report "Virtual Clinical Trials Market Share, Size, Trends, Industry Analysis Report, By Design (Observational Trials, Interventional Trials, and Expanded Access Trials); By Indication; By Phases; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increased research and development activities, healthcare digitization, and the adoption of telehealth drive the virtual clinical trials market. These factors enable seamless integration of virtual trials, remote participation, and monitoring in clinical studies. Collaborations between organizations and supportive government initiatives contribute to the market's growth. These trends emphasize the industry's focus on virtual methods, which offer flexibility, efficiency, and improved patient engagement in clinical trials.

The COVID-19 pandemic has profoundly impacted clinical trials, leading to increased adoption of virtual trials. Challenges in patient recruitment and retention have been observed, and disruptions to ongoing trials have occurred. Virtual trials emerged as a crucial solution during the pandemic, allowing participants to participate from home and ensuring research continuity when site visits were impossible.

Virtual trials offer numerous advantages, including remote data collection, increased participant engagement, and larger population inclusion. They minimize risks associated with in-person visits and reduce the burden on participants, coordinators, and investigators. By leveraging virtual methods, the clinical trials industry can overcome challenges, improve efficiency, and facilitate prompt and effective data collection.

Virtual Clinical Trials Market Report Highlights

The interventional design segment dominated the market in 2022, driven by the need for innovative medications and the increased demand for trials amidst the COVID-19 pandemic.

The oncology segment led the market in 2022 and is expected to maintain its dominance due to the rising incidence of cancer and the adoption of virtual trials for patient safety during the COVID-19 pandemic.

North America holds a significant revenue share in the global virtual clinical trials market, driven by major pharmaceutical companies, government investments, and collaborations like Janssen and PRA Health Sciences' decentralized Canagliflozin study for heart failure patients.

The global key market players include: LEO Innovation Lab, Covance Inc., CRF Health, Oracle Corporation, Medable, Inc., Paraxel International, Clinical Ink, Inc., PRA Health Sciences, Science 37, and ICON plc.

Polaris Market Research has segmented the Virtual Clinical Trials market report based on design, indication, phases, and region:

Virtual Clinical Trials, Design Outlook (Revenue - USD Million, 2019 - 2032)

  • Observational Trials
  • Interventional Trials
  • Expanded Access Trials

Virtual Clinical Trials, Indication Outlook (Revenue - USD Million, 2019 - 2032)

  • CNS
  • Autoimmune/Inflammation
  • Cardiovascular Disease
  • Metabolic/Endocrinology
  • Infectious Disease
  • Oncology
  • Genitourinary
  • Ophthalmology

Virtual Clinical Trials, Phases Outlook (Revenue - USD Million, 2019 - 2032)

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Virtual Clinical Trials, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Virtual Clinical Trials Market Insights

  • 4.1. Virtual Clinical Trials Market - Phases Snapshot
  • 4.2. Virtual Clinical Trials Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Advancements in Technology
      • 4.2.1.2. Researchers to access a more diverse and global patient population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Security and Privacy Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Virtual Clinical Trials Market Phases Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Virtual Clinical Trials Market, by Design

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • 5.3. Observational Trials
    • 5.3.1. Global Virtual Clinical Trials Market, by Observational Trials, by Region, 2019-2032 (USD Million)
  • 5.4. Interventional Trials
    • 5.4.1. Global Virtual Clinical Trials Market, by Interventional Trials, by Region, 2019-2032 (USD Million)
  • 5.5. Expanded Access Trials
    • 5.5.1. Global Virtual Clinical Trials Market, by Expanded Access Trials, by Region, 2019-2032 (USD Million)

6. Global Virtual Clinical Trials Market, by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 6.3. CNS
    • 6.3.1. Global Virtual Clinical Trials Market, by CNS, by Region, 2019-2032 (USD Million)
  • 6.4. Autoimmune/Inflammation
    • 6.4.1. Global Virtual Clinical Trials Market, by Autoimmune/Inflammation, by Region, 2019-2032 (USD Million)
  • 6.5. Cardiovascular Disease
    • 6.5.1. Global Virtual Clinical Trials Market, by Cardiovascular Disease, by Region, 2019-2032 (USD Million)
  • 6.6. Metabolic/Endocrinology
    • 6.6.1. Global Virtual Clinical Trials Market, by Metabolic/Endocrinology, by Region, 2019-2032 (USD Million)
  • 6.7. Infectious Disease
    • 6.7.1. Global Virtual Clinical Trials Market, by Infectious Disease, by Region, 2019-2032 (USD Million)
  • 6.8. Oncology
    • 6.8.1. Global Virtual Clinical Trials Market, by Oncology, by Region, 2019-2032 (USD Million)
  • 6.9. Genitourinary
    • 6.9.1. Global Virtual Clinical Trials Market, by Genitourinary, by Region, 2019-2032 (USD Million)
  • 6.10. Ophthalmology
    • 6.10.1. Global Virtual Clinical Trials Market, by Ophthalmology, by Region, 2019-2032 (USD Million)

7. Global Virtual Clinical Trials Market, by Phases

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • 7.3. Phase I
    • 7.3.1. Global Virtual Clinical Trials Market, by Phase I, By Region, 2019-2032 (USD Million)
  • 7.4. Phase II
    • 7.4.1. Global Virtual Clinical Trials Market, by Phase II, By Region, 2019-2032 (USD Million)
  • 7.5. Phase III
    • 7.5.1. Global Virtual Clinical Trials Market, by Phase III, By Region, 2019-2032 (USD Million)
  • 7.6. Phase IV
    • 7.6.1. Global Virtual Clinical Trials Market, by Phase IV, By Region, 2019-2032 (USD Million)

8. Global Virtual Clinical Trials Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Virtual Clinical Trials Market - North America
    • 8.3.1. North America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.3.2. North America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.3.3. North America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.3.4. Virtual Clinical Trials Market - U.S.
      • 8.3.4.1. U.S.: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.3.5. Virtual Clinical Trials Market - Canada
      • 8.3.5.1. Canada: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.4. Virtual Clinical Trials Market - Europe
    • 8.4.1. Europe: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.4.3. Europe: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.4. Virtual Clinical Trials Market - UK
      • 8.4.4.1. UK: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.5. Virtual Clinical Trials Market - France
      • 8.4.5.1. France: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.5.3. France: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.6. Virtual Clinical Trials Market - Germany
      • 8.4.6.1. Germany: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.7. Virtual Clinical Trials Market - Italy
      • 8.4.7.1. Italy: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.8. Virtual Clinical Trials Market - Spain
      • 8.4.8.1. Spain: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.9. Virtual Clinical Trials Market - Netherlands
      • 8.4.9.1. Netherlands: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.4.10. Virtual Clinical Trials Market - Russia
      • 8.4.10.1. Russia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.5. Virtual Clinical Trials Market - Asia Pacific
    • 8.5.1. Asia Pacific: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.4. Virtual Clinical Trials Market - China
      • 8.5.4.1. China: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.4.3. China: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.5. Virtual Clinical Trials Market - India
      • 8.5.5.1. India: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.5.3. India: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.6. Virtual Clinical Trials Market - Malaysia
      • 8.5.6.1. Malaysia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.7. Virtual Clinical Trials Market - Japan
      • 8.5.7.1. Japan: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.8. Virtual Clinical Trials Market - Indonesia
      • 8.5.8.1. Indonesia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.5.9. Virtual Clinical Trials Market - South Korea
      • 8.5.9.1. South Korea: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.6. Virtual Clinical Trials Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.4. Virtual Clinical Trials Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.5. Virtual Clinical Trials Market - UAE
      • 8.6.5.1. UAE: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.6. Virtual Clinical Trials Market - Israel
      • 8.6.6.1. Israel: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.6.7. Virtual Clinical Trials Market - South Africa
      • 8.6.7.1. South Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • 8.7. Virtual Clinical Trials Market - Latin America
    • 8.7.1. Latin America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.7.4. Virtual Clinical Trials Market - Mexico
      • 8.7.4.1. Mexico: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.7.5. Virtual Clinical Trials Market - Brazil
      • 8.7.5.1. Brazil: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
    • 8.7.6. Virtual Clinical Trials Market - Argentina
      • 8.7.6.1. Argentina: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. LEO Innovation Lab
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Covance Inc
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. CRF Health
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Oracle Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Medable, Inc
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Paraxel International
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Clinical Ink, Inc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. PRA Health Sciences
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Science 37
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. ICON plc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 2 Global Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 3 Global Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 4 Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 6 North America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 7 North America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 8 U.S.: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 9 U.S.: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 10 U.S.: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 11 Canada: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 12 Canada: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 13 Canada: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 14 Europe: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 15 Europe: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 16 Europe: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 17 UK: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 18 UK: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 19 UK: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 20 France: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 21 France: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 22 France: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 23 Germany: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 24 Germany: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 25 Germany: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 26 Italy: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 27 Italy: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 28 Italy: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 29 Spain: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 30 Spain: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 31 Spain: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 32 Netherlands: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 33 Netherlands: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 34 Netherlands: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 35 Russia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 36 Russia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 37 Russia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 41 China: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 42 China: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 43 China: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 44 India: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 45 India: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 46 India: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 47 Malaysia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 48 Malaysia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 49 Malaysia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 50 Japan: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 51 Japan: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 52 Japan: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 53 Indonesia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 54 Indonesia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 55 Indonesia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 56 South Korea: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 57 South Korea: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 58 South Korea: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 65 UAE: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 66 UAE: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 67 UAE: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 68 Israel: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 69 Israel: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 70 Israel: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 71 South Africa: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 72 South Africa: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 73 South Africa: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 74 Latin America: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 75 Latin America: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 76 Latin America: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 77 Mexico: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 78 Mexico: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 79 Mexico: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 80 Brazil: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 81 Brazil: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 82 Brazil: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)
  • Table 83 Argentina: Virtual Clinical Trials Market, by Design, 2019-2032 (USD Million)
  • Table 84 Argentina: Virtual Clinical Trials Market, by Indication, 2019-2032 (USD Million)
  • Table 85 Argentina: Virtual Clinical Trials Market, by Phases, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Virtual Clinical Trials Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Indication
  • Figure 7. Global Virtual Clinical Trials Market, by Indication, 2022 & 2032 (USD Million)
  • Figure 8. Market by Design
  • Figure 9. Global Virtual Clinical Trials Market, by Design, 2022 & 2032 (USD Million)
  • Figure 10. Market by Phases
  • Figure 11. Global Virtual Clinical Trials Market, by Phases, 2022 & 2032 (USD Million)
  • Figure 12. Virtual Clinical Trials Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Virtual Clinical Trials Market